share_log

Reneo Pharmaceuticals: Q4 Earnings Insights

Benzinga ·  Mar 28 08:00

Reneo Pharmaceuticals (NASDAQ:RPHM) reported its Q4 earnings results on Thursday, March 28, 2024 at 07:35 AM.

Here's what investors need to know about the announcement.

Earnings

Reneo Pharmaceuticals missed estimated earnings by -13.0%, reporting an EPS of $-0.7 versus an estimate of $-0.62.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 1.0% increase in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Reneo Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment